Summary:
Nathealth has called NITI Aayog to streamline the regulatory scenario in India’s healthcare sector. In the recently released white paper, the industry bodies identify 12 important regulatory hurdles that are obstructing the development and efficiency of healthcare providers, clinical centers and medtech companies.
Digital Platform and Deemed Approvals
In an important step with the aim of streamlining India’s healthcare regulator landscape, the apex body representing the NATHEALTH- Indian Health Services Ecosystem has approached NITI Aayog, demanding immediate policy intervention to reduce the increasing compliance burden on healthcare providers and new -intellectuals.
In the recently released white paper, NATHEALTH has 12 major regulatory hurdles that currently disrupt the functioning of hospitals, diagnostic labs and medtech companies. The industry body argues that the existing fragmented and often over -wide regulatory structures have adequate challenges for operating efficiency, scalability and innovation.
Also Read:
Domestic Medical Device Firms Eye Growth Under India-UK FTA, Call for Greater Transparency
The paper regulator asks for a paradigm change in the approach, urging the government’s think tank to lead the construction of an integrated national compliance forum. It will centralize the approval, licensing and reporting mechanisms, dramatically and delayed, according to the digital platform, NATHEALTH.
Major recommendations have the beginning of understanding approval – where if an application is not rejected within the specified time limit, it is considered automatically approved. This is the argument of NATHEALTH, will ensure accountability and reduce bureaucracy obstacles that often slow down significant health care operations.
White paper also emphasizes the importance of harmonious standards in states and regions. Currently, healthcare providers often face different rules for equal services in different states, leading to high cost of confusion, disability and compliance. A harmonious, PAN-India regulatory structure will create stability, improve compliance rates, and increase the ease of trading in healthcare.
“India’s healthcare sector is ready for exponential growth, but the regulatory landscape must develop to support that ambition,” said a NATHEALTH spokesperson. “A very complex, multi -level compliance is the valuable time and resources of governance drains that can be better spent in furthering quality care and innovation.”
Nathealth call for improvement comes at a time when the healthcare industry is becoming increasingly dependent on digital tools, data-driven diagnosis and next-gene medical technologies. Regulatory clarity and ease of compliance are seen as necessary to promote innovation in these emerging areas, especially in medtech and digital health solutions.
The white paper has been shared with senior officials in Niti Aayog, Ministry of Health and Family Welfare and other related departments. Nathelth hopes that the government will call a multi-interest holder task force to take action on its recommendations and set a roadmap for regulatory changes in Indian Health Services.
As India aims to expand access to inexpensive and quality healthcare for its large population, regulator reform remains an important promoter. Industry leaders argue that lowering compliance is not about cutting corners – it is about enabling hospitals, laboratories and innovators to work more efficiently while maintaining the patients of patient safety and accountability.
If adopted, the recommendations of NATHEALTH can mark an important point on how to control healthcare in India – rapid growth, broader access and enabling more flexible health ecosystems.
Disclaimer:
(The views expressed are solely on the basis of research. Indiagnostic shall not be responsible for any damage caused to any person/organization directly or indirectly).







